2004
DOI: 10.1097/01.ccm.0000120054.32845.a6
|View full text |Cite
|
Sign up to set email alerts
|

Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients

Abstract: Norepinephrine may be more predictable and efficient to augment cerebral perfusion in patients with traumatic brain injury.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
55
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 127 publications
(57 citation statements)
references
References 25 publications
1
55
0
Order By: Relevance
“…9,10 Maintaining CPP within these levels is often managed by use of vasoactive agents to increase CPP and optimize CBF. However, vasoactive agents clinically used to elevate MAP to increase CPP after TBI, such as phenylephrine (Phe), dopamine (DA), and norepinephrine (NE), [11][12][13] have not sufficiently been compared regarding effect on CPP, CBF, autoregulation, and survival after TBI, and clinically, current vasoactive agent use is variable.…”
Section: Introductionmentioning
confidence: 99%
“…9,10 Maintaining CPP within these levels is often managed by use of vasoactive agents to increase CPP and optimize CBF. However, vasoactive agents clinically used to elevate MAP to increase CPP after TBI, such as phenylephrine (Phe), dopamine (DA), and norepinephrine (NE), [11][12][13] have not sufficiently been compared regarding effect on CPP, CBF, autoregulation, and survival after TBI, and clinically, current vasoactive agent use is variable.…”
Section: Introductionmentioning
confidence: 99%
“…However, Johnston et al [21] showed that although there was no difference in ICP and cerebral oxygenation between dopamine and norepinephrine, dopamine had a more variable effect on arterial venous oxygen difference than norepinephrine. The third study showed no difference in mean ICP between dopamine and norepinephrine, yet reported that norepinephrine had predictable and significant increases in the mean flow velocity within the middle cerebral artery, whereas results with dopamine were variable and inconsistent [22]. These studies suggest that norepinephrine may be the preferred vasopressor to augment blood pressure after TBI.…”
Section: Discussionmentioning
confidence: 97%
“…However, 2 out of the 3 studies comparing dopamine and norepinephrine found that cerebral blood flow was better with norepinephrine [17,18]. There are 3 small (n = 19, 11, 10) human adult studies (prospective crossover trials) comparing the use of dopamine versus norepinephrine to augment CPP in adult TBI patients [20,21,22]. In 1 study, ICP was higher with dopamine than norepinephrine for the same MAP [20].…”
Section: Discussionmentioning
confidence: 99%
“…Prospective comparative studies regarding vasopressor selection are lacking in this population. These authors recommend against the use of dopamine because of the arrhythmogenic potential that has been observed in clinical trials and unreliable effects of dopamine on cerebral blood flow [16,19]. …”
Section: Subarachnoid Hemorrhagementioning
confidence: 97%